Quarter Period Consolidated Statement Of Comprehensive Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7262351

Concept 2024-03-01 to
2025-02-28
2024-03-01 to
2025-02-28
2024-03-01 to
2025-02-28
2024-03-01 to
2025-02-28
2024-03-01 to
2025-02-28
2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
16,363,000,000 JPY
22,301,000,000 JPY
16,363,000,000 JPY
16,363,000,000 JPY
16,363,000,000 JPY
14,431,000,000 JPY
9,855,000,000 JPY
9,855,000,000 JPY
9,855,000,000 JPY
9,855,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-3,580,000,000 JPY
4,887,000,000 JPY
Foreign currency translation adjustment
9,764,000,000 JPY
5,874,000,000 JPY
Remeasurements of defined benefit plans, net of tax
1,039,000,000 JPY
428,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
21,000,000 JPY
104,000,000 JPY
Other comprehensive income
7,244,000,000 JPY
11,295,000,000 JPY
Comprehensive income
29,546,000,000 JPY
25,727,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
28,954,000,000 JPY
25,193,000,000 JPY
Comprehensive income attributable to non-controlling interests
592,000,000 JPY
533,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.